Abstract
A case of histologically proven dilated cardiomyopathy and a case of clinically diagnosed cardiomyopathy (cardiac amyloidosis was strongly suspected but was not confirmed) were examined with99mTc(V)-dimercaptosuccinic acid (DMSA).99mTc(V)-DMSA accumulation in the damaged myocardium was clearly demonstrated. These results suggested the possibility that99mTc(V)-DMSA could be used as a positive agent for cardiomyopathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ohta H, Okada T, Furukawa Y, et al: Tc-99m(V) DMSA uptake in cardiac amyloidosis.Clin Nucl Med 16: 673–675, 1991
Ohta H, Yamamoto K, Endo K, et al: A new imaging agent for medullary carcinoma of the thyroid.J Nucl Med 25: 323–325, 1984
Wulfrank DA, Schelstraete KH, Pharm FS, et al: Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.Clin Nucl Med 14: 588–593, 1989
Ohta H, Endo K, Fujita T, et al: Clinical valuation of tumor imaging using99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.Nucl Med Commun 9: 105–116, 1988
Yokoyama A, Saji H: Tumor diagnosis using radioactive metal ions and their complexes. InMetal Ions in Biological Systems, Volume 10, Siegel H (ed), New York, Marcel Dekker, pp 313–340, 1980
Toyo-oka T, Nagayama K:In vivo tissue characterization of myocardium with cardiomyopathy using1Hand31P-NMR spectroscopy. InMyocarditis and Related Disorders, Sekiguchi M, Olson JJH, Goodwin JF (ed), Heidelberg, Springer Verlag, pp 50–53, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ohta, H., Komibuchi, T., Kawamata, S. et al. Positive imaging of cardiomyopathy with99mTc(V)-DMSA. Ann Nucl Med 6, 269–271 (1992). https://doi.org/10.1007/BF03164665
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03164665